Mortada I, Lee A, Sahu A, Nwaogu C, et al. Additive Cardiorenal Benefits of Finerenone and SGLT2 Inhibitor Combination Therapy in Diabetic CKD: A Propensity-Matched Real-World Study. Am J Cardiol 2026 Feb 27:S0002-9149(26)00089.
PMID: 41765258